DK3663292T3 - Diphenylmethan-derivat i krystallinsk form - Google Patents

Diphenylmethan-derivat i krystallinsk form Download PDF

Info

Publication number
DK3663292T3
DK3663292T3 DK20152959.1T DK20152959T DK3663292T3 DK 3663292 T3 DK3663292 T3 DK 3663292T3 DK 20152959 T DK20152959 T DK 20152959T DK 3663292 T3 DK3663292 T3 DK 3663292T3
Authority
DK
Denmark
Prior art keywords
diphenylmethan
derivative
crystallinic
crystallinic form
diphenylmethan derivative
Prior art date
Application number
DK20152959.1T
Other languages
Danish (da)
English (en)
Inventor
Hee-Kyoon Yoon
Se-Hwan Park
Ji-Sung Yoon
Soongyu Choi
Hee Jeong Seo
Eun-Jung Park
Younggyu Kong
Kwang-Seop Song
Min Ju Kim
So Ok Park
Original Assignee
Dae Woong Pharma
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60664449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3663292(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dae Woong Pharma, Green Cross Corp filed Critical Dae Woong Pharma
Application granted granted Critical
Publication of DK3663292T3 publication Critical patent/DK3663292T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B51/00Introduction of protecting groups or activating groups, not provided for in the preceding groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK20152959.1T 2016-06-17 2017-06-15 Diphenylmethan-derivat i krystallinsk form DK3663292T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160075910 2016-06-17
EP17813615.6A EP3473621B1 (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative

Publications (1)

Publication Number Publication Date
DK3663292T3 true DK3663292T3 (da) 2021-10-25

Family

ID=60664449

Family Applications (2)

Application Number Title Priority Date Filing Date
DK20152959.1T DK3663292T3 (da) 2016-06-17 2017-06-15 Diphenylmethan-derivat i krystallinsk form
DK17813615.6T DK3473621T3 (da) 2016-06-17 2017-06-15 Fremgangsmåde til fremstilling af diphenylmethan-derivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17813615.6T DK3473621T3 (da) 2016-06-17 2017-06-15 Fremgangsmåde til fremstilling af diphenylmethan-derivat

Country Status (29)

Country Link
US (2) US10640496B2 (enExample)
EP (2) EP3663292B1 (enExample)
JP (4) JP6763978B2 (enExample)
KR (2) KR102233229B1 (enExample)
CN (2) CN113651803B (enExample)
AU (1) AU2017285813B2 (enExample)
CA (2) CA3026756C (enExample)
CL (1) CL2018003645A1 (enExample)
CO (1) CO2018014018A2 (enExample)
DK (2) DK3663292T3 (enExample)
DO (1) DOP2018000287A (enExample)
EC (1) ECSP19000185A (enExample)
ES (2) ES2891825T3 (enExample)
HR (1) HRP20211670T8 (enExample)
HU (1) HUE056428T2 (enExample)
MA (2) MA50774B1 (enExample)
MX (2) MX392177B (enExample)
MY (1) MY203941A (enExample)
NZ (1) NZ749398A (enExample)
PE (2) PE20190467A1 (enExample)
PH (1) PH12018550206A1 (enExample)
PL (2) PL3473621T3 (enExample)
PT (2) PT3473621T (enExample)
RS (1) RS62550B1 (enExample)
SA (2) SA521422474B1 (enExample)
SG (2) SG11201811154QA (enExample)
SI (1) SI3663292T1 (enExample)
TN (1) TN2018000437A1 (enExample)
WO (1) WO2017217792A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011054773A1 (de) 2011-10-25 2013-04-25 Vb Autobatterie Gmbh & Co. Kgaa Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols
PE20211206A1 (es) * 2018-08-13 2021-07-05 Dae Woong Pharma Preparacion de intermedio util para la sintesis de inhibidor de sglt
CN112341416A (zh) * 2019-08-09 2021-02-09 天津津艺医药科技发展有限责任公司 一种制备苯并含氧脂杂环衍生物的方法
WO2021172955A1 (ko) * 2020-02-27 2021-09-02 주식회사 대웅제약 Sglt 저해제의 합성에 유용한 중간체 및 이를 이용한 sglt 저해제의 제조 방법
US12448360B2 (en) * 2020-09-10 2025-10-21 Daewoong Pharmaceutical Co., Ltd. Synthesis method for preparing SGLT inhibitor intermediate
CN112094253B (zh) * 2020-09-10 2023-01-10 株式会社大熊制药 用于制备sglt抑制剂中间体的合成方法
CN113200860B (zh) * 2021-04-29 2024-07-30 爱斯特(成都)生物制药股份有限公司 一种sglt2抑制剂中间体的制备方法
KR20230046784A (ko) * 2021-09-30 2023-04-06 주식회사 대웅제약 이나보글리플로진을 포함하는 약학 조성물
CN113801010A (zh) * 2021-11-18 2021-12-17 山东诚创蓝海医药科技有限公司 一种5-溴-2-氯苯甲酸的制备方法
CN113912487B (zh) * 2021-11-23 2024-05-28 山东研峰新材料科技有限公司 一种2,5-双卤代苯甲酸的合成方法
KR20230110001A (ko) * 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법
KR20240044190A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법
KR20240044194A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 공결정
CN119968202A (zh) 2022-09-29 2025-05-09 株式会社大熊制药 用于预防或治疗心血管衰老疾病的包含依那格列净的药物组合物
KR20240047952A (ko) 2022-10-05 2024-04-12 주식회사 대웅제약 이나보글리플로진을 포함하는 신장애 및/또는 당뇨병 예방 또는 치료용 약학 조성물
EP4631498A1 (en) 2022-12-21 2025-10-15 Daewoong Therapeutics Inc. Eye drop-type pharmaceutical composition containing envogliflozin
KR20240107660A (ko) 2022-12-30 2024-07-09 주식회사 대웅제약 이나보글리플로진 및 메트포르민을 포함하는 약학 조성물
KR102853437B1 (ko) * 2024-11-13 2025-09-04 대웅바이오(주) 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102837948B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) 분배 투입법을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102837941B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) Inline quenching 공정을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
EP2514756B1 (en) * 2003-08-01 2014-12-17 Mitsubishi Tanabe Pharma Corporation Novel compounds having inhibitory activity against sodium-dependant glucose transporter
WO2009014970A1 (en) 2007-07-26 2009-01-29 Lexicon Pharmaceuticals, Inc. Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
WO2010012789A1 (en) 2008-07-30 2010-02-04 Ferrer Internacional S. A. 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
WO2012041898A1 (en) 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
KR101576589B1 (ko) * 2011-06-01 2015-12-10 주식회사 녹십자 Sglt2 억제제로서의 신규한 다이페닐메탄 유도체
US9340521B2 (en) 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PE20190467A1 (es) 2019-04-04
KR20170142904A (ko) 2017-12-28
CN113651803A (zh) 2021-11-16
MX2021008988A (es) 2022-05-05
US20190382390A1 (en) 2019-12-19
SG10201911782RA (en) 2020-02-27
EP3663292B1 (en) 2021-09-01
US10889574B2 (en) 2021-01-12
PT3473621T (pt) 2021-10-04
ES2898336T3 (es) 2022-03-07
SA518400666B1 (ar) 2021-11-30
JP2021152054A (ja) 2021-09-30
JP6763978B2 (ja) 2020-09-30
CN113651803B (zh) 2022-10-28
EP3473621B1 (en) 2021-08-04
PT3663292T (pt) 2021-11-08
HUE056428T2 (hu) 2022-02-28
DK3473621T3 (da) 2021-09-06
US20190169174A1 (en) 2019-06-06
CO2018014018A2 (es) 2019-03-08
RU2021129636A (ru) 2021-11-22
AU2017285813A1 (en) 2019-01-17
HRP20211670T8 (hr) 2022-03-18
EP3473621A4 (en) 2020-03-11
NZ749398A (en) 2020-01-31
KR20210036892A (ko) 2021-04-05
WO2017217792A1 (ko) 2017-12-21
PL3473621T3 (pl) 2022-01-10
PH12018550206A1 (en) 2019-09-30
MX2018015647A (es) 2019-04-11
ES2891825T3 (es) 2022-01-31
MA44545B2 (fr) 2020-11-30
JP7669206B2 (ja) 2025-04-28
EP3663292A1 (en) 2020-06-10
JP7773506B2 (ja) 2025-11-19
MY203941A (en) 2024-07-25
PE20240590A1 (es) 2024-03-21
CN109311861B (zh) 2021-08-24
JP2020117528A (ja) 2020-08-06
JP2019521985A (ja) 2019-08-08
CA3081033C (en) 2022-04-12
SG11201811154QA (en) 2019-01-30
BR112018076243A2 (pt) 2019-03-26
MA44545B1 (fr) 2020-05-29
TN2018000437A1 (en) 2020-06-15
MA44545A1 (fr) 2019-10-31
AU2017285813B2 (en) 2020-02-06
ECSP19000185A (es) 2019-01-31
CA3026756C (en) 2021-03-02
KR102379584B1 (ko) 2022-03-29
CN109311861A (zh) 2019-02-05
DOP2018000287A (es) 2019-03-31
EP3473621A1 (en) 2019-04-24
MX392177B (es) 2025-03-19
RU2019101056A (ru) 2020-07-17
CA3026756A1 (en) 2017-12-21
JP7352509B2 (ja) 2023-09-28
SA521422474B1 (ar) 2023-11-02
HRP20211670T1 (hr) 2022-02-18
CL2018003645A1 (es) 2019-03-22
RS62550B1 (sr) 2021-12-31
PL3663292T3 (pl) 2022-01-17
RU2019101056A3 (enExample) 2020-07-17
MA50774A1 (fr) 2021-03-31
SI3663292T1 (sl) 2022-01-31
MX385640B (es) 2025-03-18
MA50774B1 (fr) 2022-02-28
KR102233229B1 (ko) 2021-03-29
CA3081033A1 (en) 2017-12-21
JP2023145481A (ja) 2023-10-11
US10640496B2 (en) 2020-05-05

Similar Documents

Publication Publication Date Title
DK3663292T3 (da) Diphenylmethan-derivat i krystallinsk form
DK3405050T3 (da) Børnesikret snusbeholder
EP3440949A4 (en) FLAVOR INHALER
EP3446605A4 (en) HAND VACUUM
DK3436823T3 (da) Antigen-array
DK3335532T3 (da) Tandharve
LT3402792T (lt) Chinolin-2-ono dariniai
LT3457851T (lt) Sobetiromo dariniai
DK3445708T3 (da) Stigbøjle
EP3402022A4 (en) GRAB WIRE
LT3371168T (lt) Indolin-2-ono dariniai
EP3541200C0 (en) POWDERED FORMULATIONS
EP3402021A4 (en) GRAB WIRE
DK3509963T3 (da) Pallecontainer
DK3452590T3 (da) Plademagnet
DK3575238T3 (da) Pallecontainer
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
EP3443854A4 (en) AROMA INHALER
EP3399976C0 (en) BENZOTHIAZOLE AMPHOPHILES
EP3444345C0 (en) MICRO-143 RNA DERIVATIVE
EP3455282A4 (en) POLYSILOXANE-BASED HYDRAULIC FLUIDS
DE112017000734A5 (de) Glycolsensor
DE112017006386A5 (de) Schraubarbeitszylinder
DK3323708T3 (da) Bovfender
DK3452587T3 (da) Penicillin-g-acylaser